Stock AUPH AURINIA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Aurinia Pharmaceuticals Inc.

Equities

AUPH

CA05156V1022

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
5.42 USD +0.74% Intraday chart for Aurinia Pharmaceuticals Inc. +4.03% -39.71%
May. 14 Aurinia Pharmaceuticals Inc. Presented Results from the Analysis Showing Lupkynis A Cost-Effective Treatment for Lupus Nephritis Presented At National Kidney Foundation's Spring Clinical Meeting 2024 CI
May. 07 Lucien Selce Urges Aurinia Pharmaceuticals Board to Take Action to Enhance Shareholder Value CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
AURINIA PHARMACEUTICALS INC.
Bio Therapeutic Drugs
+0.74%+4.03%-39.71%-39.51%-16.36% 773M
Neutral
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. AUPH Stock
  4. Charts Aurinia Pharmaceuticals Inc.
  5. Comparison Chart